These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12814712)

  • 1. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H; Fellström B; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Solbu DO; Pedersen TR;
    Lancet; 2003 Jun; 361(9374):2024-31. PubMed ID: 12814712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
    Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
    Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
    Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
    Jardine AG; Holdaas H; Fellström B; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Holme I; Fauchald P; Gimpelwicz C; Pedersen TR;
    Am J Transplant; 2004 Jun; 4(6):988-95. PubMed ID: 15147434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H; Fellström B; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Logan JO; Staffler B; Gimpelewicz C;
    Nephrol Dial Transplant; 2005 May; 20(5):974-80. PubMed ID: 15784644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
    Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
    Holdaas H; Fellström B; Holme I; Nyberg G; Fauchald P; Jardine A; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Weinreich T; Olsson AG; Pedersen TR; Benghozi R; Hartmann A;
    J Cardiovasc Risk; 2001 Apr; 8(2):63-71. PubMed ID: 11324372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study.
    O'Rourke B; Barbir M; Mitchell AG; Yacoub MH; Banner NR
    Int J Cardiol; 2004 Apr; 94(2-3):235-40. PubMed ID: 15093987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
    Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
    Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Logan JO; Pedersen TR;
    Kidney Int; 2004 Oct; 66(4):1549-55. PubMed ID: 15458450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
    Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
    Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
    Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
    Holdaas H; Jardine AG; Wheeler DC; Brekke IB; Conlon PJ; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe PA; Sweny P; Talbot DA; Wadstrøm J; Østraat Ø
    Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives.
    Anderssen SA; Hjelstuen AK; Hjermann I; Bjerkan K; Holme I
    Atherosclerosis; 2005 Feb; 178(2):387-97. PubMed ID: 15694949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.